Serum paraoxonase-1 (PON1) binds mainly to high density lipoproteins (HDLs) 
Introduction
Paraoxonase-1 (PON1), a member of the paraoxonase family, is synthesized in the liver and transported in the plasma mainly by the high density lipoprotein (HDL) particles from where it can be transferred in the areas of low density lipoprotein (LDL) accumulation, where it prevents its oxidation (1) . From a functional perspective, PON1 hydrolyzes a broad spectrum of molecules ranging from organophosphates (OPs) to lactones (2) , as it performs multiple tasks depending on its substrate and networking capacity of its active center residues (3). While paraoxonase (Po.ase) and arylesterase (Ar.ase) activities are being traditionally assayed, lactonase (Lct. ase) activity, which accounts for HDL-mediated protection against LDL oxidation (4), has been less investigated. These activities are modulated by single nucleotide polymorphisms in the promoter (mainly c.-108C>T or rs705379) and the coding region (p.Leu55Met or rs854560 and p.Gln192Arg or rs662) of the PON1 gene. While the c.-108C>T and the p.Leu55Met polymorphisms influence enzyme concentration and stability (5), the Gln-to-Arg substitution at position 192 accounts for great variations of the Po.ase activity (6) , from the Gln (Q) isoform with the lowest activity to the Arg (R) isoform with the highest activity (7) . Furthermore, oxidative stress influences the three activities differently, Lct.ase being the most susceptible (8) .
Childhood obesity, defined as a body mass index (BMI) higher than the 95 th percentile for the same age and sex, is a major public health issue affecting millions of children worldwide. Excessive adiposity increases the risk for atherosclerosis-related coronary artery disease by promoting inflammation, oxidative stress and high plasma cholesterol levels, which negatively influence PON1 gene transcription (9) and activity (8) . In adults, low PON1 levels are associated with conditions that involve lipid peroxidation and systemic inflammation such as diabetes mellitus or metabolic syndrome and are an independent risk factor for coronary heart disease (10). Furthermore, low levels of Ar.ase or Po.ase have been observed in obese children (11) (12) (13) (14) , but Lct. ase, considered the physiologic activity of PON1 (2), has scarcely been investigated in this condition (14) . Having these in mind, we undertook a complex approach to compare Lct.ase, Po.ase and Ar.ase, along with oxidized LDL (ox-LDL), malondialdehyde (MDA) and lipid profile in a group of children and adolescents with non-genetic obesity vs. normal-weight children. 
Subjects and Methods

Study population
The study population consisted of 68 children, 35 obese (OB) and 33 normal-weight (Control, C), consecutively recruited from the local Pediatric Hospitals. All participants underwent a complete standard physical examination. BMI was calculated as the ratio of the weight (expressed in kilograms, kg) to the square of height (expressed in meters, m 2 ). The children were classified as obese or normal-weight according to the WHO-BMI percentiles with the cut-off limit for the study group set at the 95 th percentile. The children had no previous dietary interventions, nor were enrolled in any physical education programmes. Children suffering from any chronic diseases (e.g. diabetes mellitus) or presenting any acute inflammatory conditions were excluded from study. An informed written consent was obtained from all the parents or legal tutors of children included in the study. The research protocol was developed in accordance with the WMA Declaration of Helsinki and was approved by the University Ethics Committee.
Blood sample collection
Venous blood samples were drawn in clot-activator vacutainers in the morning, following a 12-hour overnight fast. The serum, isolated by low-speed centrifugation, was used for lipid profile determination and the remaining quantity was immediately divided into aliquotes and stored at -80°C for later assay of PON1 activities, MDA and ox-LDL levels.
PON1 enzymatic activities PON1 Ar.ase, salt-inhibited arylesterase (siAr.ase) and salt-stimulated paraoxonase (ssPo. ase) activities were determined using phenyl acetate and paraoxon as substrates, according to Eckerson et al. (7) , with slight modifications.
Briefly, siAr.ase and Ar.ase were measured using an incubation mixture containing phenyl acetate (Sigma, USA) in 1mM CaCl 2 , 20mM Tris-HCl buffer (pH 8) with and without 1M NaCl, to which serum was added in order to initiate the reaction. The rate of substrate hydrolysis was established measuring the increase in absorbance at 270 nm. The enzymatic activity (expressed in kU/L) was calculated using the corresponding molar extinction coefficient for phenol (1,310 M -1 cm -1 ). The ssPo.ase working mixture contained 1mM paraoxon (diethyl 4-nitrophenyl phosphate, Sigma-Aldrich Chemie GmbH, Germany), 1mM CaCl 2 and 2M NaCl in 50mM glycine-NaOH buffer (pH 10.5). After adding the serum, the hydrolysis of paraoxon was recorded at 412 nm. The molar extinction coefficient of 18,290 M -1 cm -1 for p-nitrophenol was used to calculate the enzymatic activity, expressed in U/L.
Lct.ase activity (expressed in kU/L) was measured by adapting the pH-sensitive colorimetric assay proposed by Khersonsky and Tawfik (2). The reaction mixture contained 1mM δ-valerolactone (Acros Organics, Belgium) in 0.1mM m-cresol purple (from 60mM stock solution in dimethyl sulfoxide), 1mM CaCl 2 and 150mM NaCl in 2.5mM bicine buffer (pH 8.3). After adding serum to the assay mixture, the hydrogen ions release by the 5-hydroxyvaleric acid (the product of Lct.ase action) was recorded spectrophotometrically at 577 nm. The initial rate of hydrolysis was calculated using the slope value (in units of absorbance change per minute) multiplied by a rate factor derived from a standard calibration curve obtained with acetic acid. Units were defined as the number of micromoles of acid produced per time unit.
All PON1 activities were determined at 25 o C with a V-530 Spectrophotometer using a Peltier thermostated cell holder, equipped with a magnetic stirrer (Jasco, USA). A blank sample containing incubation mixture without serum was used in order to correct for the spontaneous hydrolysis of the substrate.
PON1 phenotype distribution
The ratio of ssPo.ase to siAr.ase activities (double-substrate method applied on the logarithm-transformed data) was used to identify individual phenotypes according to Eckerson et al. (7) with slight modifications. Knowing that NaCl differently influences Po.ase and Ar.ase activities, which correspond to a specific phenotype, we have used the ssPo.ase activity and the siAr.ase activity to obtain a better phenotype differentiation. The ratios were trimodally distributed on the histogram, corresponding to low activity -AA phenotype (isoform QQ), intermediate activity -AB phenotype (isoform QR) and high activity -BB phenotype (isoform RR).
Oxidized LDL (ox-LDL) levels
Serum ox-LDL levels were measured using an Oxidized LDL Competitive ELISA assay kit (Mercodia AB, Sweden) according to the manufacturer's instructions, on a Sunrise Tecan microplate reader (Tecan Group, Switzerland).
Malondialdehyde (MDA) levels
MDA levels were assayed using the fluorometric method proposed by Conti et al. (15) , on a Perkin-Elmer UK model LS 45 Fluorescence Spectrometer (Perkin Elmer, UK). MDA was treated with 1,3-diethyl-2-thiobarbituric acid in an acid medium and the resulted fluorescent compound was extracted with butanol and determined by synchronous fluorescence spectroscopy with Δλ=14 nm between the excitation (515 nm) and emission wavelengths.
Other parameters
Serum triacylglycerols (TG), HDL and total cholesterol (TC) were assayed on an Architect C4000 analyzer (Abbott, USA) using commercially available kits. LDL levels were calculated using the Friedewald formula (LDL=TC-HDL-TG/5), all subjects having TG levels below 3.9 mm/l. The atherogenic index of plasma (AIP) was expressed as logarithm of the molar ratio of TG to HDL (16) .
Statistical analysis
Qualitative data was presented as counts and percentages. The association between qualitative variables was assessed using the Chi-square test or the Fisher exact test. The normal distribution of data was checked with strip-chart, quantile-quantile plot and Shapiro-Wilk test.
Quantitative data was presented as mean and standard deviation (for normally distributed data) or by median and interquartile range (for non-normally distributed data). To check for differences between two independent groups of quantitative data, the Mann-Whitney U test (for non-normally distributed data) or the Student test (for normally distributed data) were used. The Lct.ase and Ar.ase activities were assessed against several explanatory variables: obesity (coded 1-yes, 0-no), age, gender, HDL, LDL, ox-LDL, TG and MDA. The relationship between obesity and other explanatory variables was assessed with logistic regression.
For all regression analysis we performed the univariate analysis. We built the full models and then using a stepwise backward/forward model selection based on the Akaike information criterion we selected the variables for the final models. Results were presented as coefficients/odds ratios and 95% CI. For all statistical tests the significance level alpha was set at 0.05 and the two-tailed p value was computed. The statistical analysis was performed in R environment for statistical computing and graphics, version 3.0.1 (17) .
Results
Baseline clinical and laboratory parameters of the study groups are presented in Table I .
Statistical analysis did not show significant differences regarding age, gender distribution, TG and ox-LDL. Serum TC, LDL and MDA levels were significantly higher and HDL levels were significantly lower in obese children, while AIP values were in normal limits for both groups (OB: -0.09 ± 0.21 vs. C: -0.27 ± 0.20; p<0.001).
There were no statistically significant differences between obese and control groups regard- Ar.ase and Lct.ase activities were significantly decreased in obese children compared to controls (Figure 1 ), but ssPo.ase levels were not Tables II, III and IV). The stepwise selection procedures used to build all the final regression models removed 
Discussion
The main finding of our research was that PON1 Lct.ase and Ar.ase activities, but not ssPo. ase, are decreased in the presence of excessive adiposity. Until now, relatively little effort has been made to investigate the role of PON1 in obesity, and the few published results are inconsistent. In obese adults, both low (18) (19) (20) (21) or unchanged levels of Po.ase and Ar.ase (22) have been reported. Similarly, in obese children and adolescents, either low (11, 23, 24) , unaffected levels of Po.ase and Ar.ase (25) (26) (27) or incresed levels of Ar.ase (28) have also been observed. Recently, unchanged (25) or reduced (14) levels of Lct.ase activity (assayed with dihydrocoumarin and 5-thiobutyl butyrolactone, respectively) have been reported in obese children.
The discrepancies between the data regarding PON1 activities in obese vs. control subjects could be explained by the relatively small size of the investigated groups, the great variability of PON1 activities in the same ethnic population, the complex nature of obesity (which depends on both genetic and environmental factors), and lifestyle, which could influence HDL composition and thus PON1 stability and activities. Furthermore, the differences between the methods used for assaying PON1 activities (e.g. the composition of assaying mixture) could be another cause of discrepancy. The pH-indicator assay which we used to monitor δ-valerolactone hydrolysis permits the measurement of the initial rate but not of the entire reaction course (29) . Moreover, while δ-valerolactone and phenyl acetate bind in a similar fashion to the PON1 active site and use the same catalytic mechanism, the hydrolysis of paraoxon (an aromatic phosphotriester) and of dihydrocoumarin (an aromatic lactone) uses distinctive parts of the active site network, therefore the binding and catalytic mechanisms are dissimilar (3). All the above could explain the Ar.ase and Lct.ase behavior observed in our study, and the unchanged Po.ase and Lct.ase reported by Ruperez et al. (25) in the obese group.
The association of PON1 with HDL is a prerequisite for maintaining a normal serum enzyme activity. HDL lipidic and proteic components interact in order to promote PON1 secretion as well as maintaining its stability in the blood stream (30) . As in our study, reduced HDL levels have been previously reported in obese children (11, 13, 14, 23, 25) . These alterations have been attributed to both an enhancement in the uptake of HDL by the adipocytes and an increase in the apoA-I catabolism in HDL particles. In the absence of ApoA-I, the PON1-HDL complex is less stable and PON1 loses its activity (mainly Lct.ase) faster than in normal controls (1, 10, 31, 32) . Therefore, due to a reduced level of the carrier and the instability of the PON1-HDL complex, low PON1 levels are to be expected. Accordingly, we observed that the differences between groups regarding the Ar.ase and Lct. ase activities lost their statistical significance after being divided by the HDL levels, suggesting that, in the case of the obese children, low HDL levels account, at least partially, for the diminished Ar.ase and Lct.ase.
Another factor which could affect PON1 levels is oxidative stress, observable not only in obese adults but also in obese children. In this respect, we have observed higher MDA levels (one of the end products of lipid peroxidation) in obese subjects. This increment has also been reported by Codoner-Franch et al. (21, 33) .
PON1 is involved in the protection of LDL and HDL against oxidative alteration (34) . Moreover, the enzyme is time-dependent inactivated by this process, due to an interaction of oxidized phospholipids and cholesterol esters with the free SH-group of cysteine-284 (the inhibition order to enrich the results of the present study, large prospective studies are needed and other markers of oxidative stress should be analyzed.
Conclusion
Low PON1 Lct.ase and Ar.ase activities are associated with the presence of obesity in children and adolescents. This may account for a higher susceptibility to atherosclerosis-related diseases with age.
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95% CI -95% confidence interval AIP -atherogenic index of plasma apoA-I -apolipoprotein A-I Ar.ase -arylesterase activity percent of LDL oxidation being higher than the percent lost in PON1 activity) (35) .
These interactions influence the three activities differently, Lct.ase being the most susceptible (8) . Current research indicates that the Ar.ase and mainly the Lct.ase activities are related to the protective capacity of PON1 against LDL oxidation, ox-LDL inducing the enzyme's "suicide-like" behavior by impairing the networking of its active site residues (8) . Moreover, ox-LDL can induce HDL composition alteration (10) and decrease the PON1 gene expression (9) . As obesity promotes oxidative stress, we expected to find high levels of serum ox-LDL in the obese subjects. Conversely, we did not observe statistically significant differences between the obese and the control groups, similar to Demirel et al. (36) , Kelishadi et al. (37) and Ruperez et al. (25) . Kelly et al. (38) found increased ox-LDL levels in children with excessive adiposity, significantly associated with obesity only in the older subjects (12-18 years of age). However, statistically significant differences were observed between groups regarding the ox-LDL to HDL ratio, a parameter which better evaluates the risk for further developing atherosclerosis-related complications and thus the extent of the LDL alterations induced by oxidation/oxidative stress (39) .
The unchanged ox-LDL levels in obese children could be due to a good antioxidant protection and/or an efficient and specific removal from their plasma by the macrophages and macrophage-like cells in the liver (40) . In this respect, the AIP values observed in obese children indicated a low risk of atherosclerosis-related complications (16) , as ox-LDL certainly plays an important role in atherogenesis.
The small sample size was definitely a limitation of this study, however our results underline the importance of further analyzing the relationship between PON1 and childhood obesity from the perspective of the Lct.ase activity. In BMI -body mass index HDL -high density lipoprotein Lct.ase -lactonase activity LDL -low density lipoprotein MDA -malondialdehyde n (%) -number (percentage) OPs -organophosphates OR -odds ratio ox-LDL -oxidized LDL Po.ase -paraoxonase activity PON1 -Paraoxonase-1 SD -standard deviation siAr.ase -salt-inhibited arylesterase activity ssPo.ase -salt-stimulated paraoxonase activity TC -total cholesterol TG -serum triacylglycerols
